Vitalhub Corp. · TSX:VHI
Vitalhub — Investor Presentation (October 2022)
22 slides from Vitalhub's investor presentation, October 2022
Slide 1: Investor presentation
Investor presentation OCTOBER 2022 TSX:VHI OTCQX: VHIBF
Slide 2: Reader's Advisory
Reader’s Advisory This corporate presentation dated August 2022 (the “Presentation”) has been prepared by management of VitalHub Corp. (the “Corporation”), and is based on public information and the Corporation’s confidential information. This Presentation is for information purposes only and is bei
Slide 3: Who We Are
Who We Are Synergistic M&A Growth Large, Fragmented Global Market Software Canada, UK, Consolidator Australia, Qatar, Focused on Health & Human Services UAE & Latvia Digital Solutions Sizable Organic Growth 4
Slide 4: What We Do
What We Do Patient Flow & Operational Visibility comprises 70% of Company revenue Efficient Patient Flow & 70% Optimized EHR, Case Management & of revenue Operational Visibility Care Coordination Patient Flow Solutions • 20 modules built on TREAT EHR platform ~17 products • Complete client / medical
Slide 5: VitalHub Solutions
VitalHub Solutions Patient Service-point Create a mobile appointment Journey Join a virtual clinic Appointment Portal SMS Reminders Virtual Clinics Virtual Clinics Patient check Patient registration Patient waits for Procedure performed Performance Results are shared in person in from their car at k
Slide 6: Real-Time Operational Visibility
Real-Time Operational Visibility VitalHub solutions improve transparency and communication through real-time whole system visibility, Integrated information for coordinated care, and optimization of patient movement 7
Slide 7: VitalHub Solutions – TREAT EHR System
VitalHub Solutions – TREAT EHR System Registration & Integrated care Billing, reporting Facilities Enrolment management and dashboards Social worker Doctor Administrator, Facilities / nurse Incident reporting, Billing management, Facility & Bed Client profile creation, eDocs, Teams & Assessment, Rep
Slide 8: Financial Highlights
Financial Highlights $31.2M $10M Strong institution shareholder $36M ARR debt cash on-hand base 18% Adjusted EBITDA Cash flow Trailing 12-month positive 13 80% positive organic revenue growth consecutive quarters Gross profit percentage 9
Slide 9: Market Size and Opportunity
Market Size and Opportunity $700 per bed/per year for a VitalHub patient journey product suite Our install base represents 60,000 beds across 4 countries $2.1B marketplace Substantial opportunity to sell-in VitalHub’s full product suite across Significant existing install base opportunity for compri
Slide 10: Innovations Lab
Innovations Lab 85+ Founded in 100% developers, engineers and QA professionals 2003 owned by Vitalhub Broad capabilities supporting over Supports development, quality 8 different technology environments assurance, help desk and Infrastructure 11
Slide 11: M&A Strategy
M&A Strategy Synergistic rollup strategy with a clearly defined framework for increasing growth and profitability. Cost-effective R&D Consolidate G&A Sales Optimize S&M Sell Organically The Innovation Lab One central Cross-selling & upselling Implementation of Develop and sell reduces software funct
Slide 12: M&A Model
M&A Model 1.0-2.5x Combination of Annual Revenue Revenue cash & $1-12M 60% Recurring revenue Multiple stock Breakeven or Profitable Median Deal Size Targets 400 20% owner operators with stable customer base in 20-30% Pipeline of Reduction in Target EBITDA Canada, UK, Australia acquisition targets co
Slide 13: Timeline
Timeline Patient Flow EHR, Case Management & Operational Visibility & Care Coordination Operational management Provider of Provider of unique Case systems for Award winning integrated SaaS real-time Management Web-based EHR SaaS- based Case complex hospital patient flow healthcare services informati
Slide 14: Top Line Growth
Top Line Growth $10.0 60% $9.0 53% 50% 50% $8.0 45% $7.0 $4.7 40% 41% 40% $5.839% 38% 38% $6.0 36% 35% 36% 35% $5.0 30% 29% $4.3 $4.3 $4.0 $3.8 $3.2 $3.2 20% $3.0 $4.7 $1.3 $2.3 $2.0 $1.8 $1.3 $1.5 $1.8 $3.7 10% $2.4 $2.6 $1.0 $1.9 $2.2 $2.0 $1.5 $1.1 $1.0 $1.0 $1.0 $0.9 - 0% Q2 2019 Q3 2019 Q4 2019
Slide 15: ARR - Consistent QoQ Growth
ARR - Consistent QoQ Growth ARR Quarter on quarter Growth in ARR (%) $31.2 Without Q3 growth to date ARR is $31.2M $24.0 $21.6 $22.1 $19.8 $15.9 $14.8 $13.6 $7.4 $7.5 $7.5 $5.3 $5.6 0% 81% 2% 5% 33% 1% 9% 7% 24% 9% 2% 9% 30% Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 Q3_2020 Q4_2020 Q1_2021 Q2 2021 Q3
Slide 16: Revenues – last twelve quarters
Revenues – last twelve quarters Term licences, maintenance and support Perpetual licences Services and other Total revenue % Recurring revenues $10.0 90% $9.0 80% $8.0 70% $7.0 60% $6.0 50% $5.0 40% $4.0 30% $3.0 20% $2.0 $1.0 10% - 0% Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 Q3_2020 Q4_2020 Q1_2021
Slide 17: Revenues and Adjusted EBITDA
Revenues and Adjusted EBITDA Total revenue Adjusted EBITDA Adjusted EBITDA Margin % $10.0 35% 32% $9.0 30% $8.0 $7.0 25% $6.0 20% 20% 20% $5.0 18% 19% 16% 15% $4.0 16% 14% $3.0 10% $2.0 5% $1.0 - 0% TSX VHI Q3_2020 Q4_2020 Q1_2021 Q2 2021 Q3 2021 Q4 2021 Q1_2022 Q2 2022 21
Slide 18: Capitalization Table
Capitalization Table Basic Shares Outstanding 43,400,000 Stock Options & DSUs 2,746,000 Fully Diluted Shares Outstanding 46,146,000 Net Cash Position 26,000,000 Insider Ownership 28% Enterprise Value (based on a $2.67 share price) $89.9MM Public shareholders Management control Source: Public filings
Slide 19: Comparable Table
Comparable Table Mkt. EV/Sales EV/EBITDA % Rec Gross EBITDA 2-yr fwd. CAGR Ticker Cap 2021A 2022E 2023E 2021A 2022E 2023E Revenue Margins Margins Rev. EBITDA VitalHub Corp. VHI $130 4.4x 2.8x 2.5x 23.9x 12.1x 10.1x 78% 79% 18% 33% 54% Enterprise Value (based on a $2.75 share price) : $97.8MM Softwar
Slide 20: Management
Management Dan Matlow President & CEO Vijit Coomara EVP of Development ▪ 30 years of experience in technology with a focus on ▪ 30 years of experience in Development and Health IT Technology ▪ Previously CEO & Founder at Medworxx ▪ Previously CTO & Co-Founder at B Sharp ▪ Track record of building an
Slide 21: Board of Directors
Board of Directors Dan Matlow Barry Tissenbaum ▪ 30 years experience in technology field with focus on Health IT ▪ Retired former Senior Partner with Ernst & Young ▪ Track record of building and growing enterprise software companies ▪ Currently serves on the Noranda Income Fund Board, and is Chairma
Slide 22: Why Invest
Why Invest Compelling Strong, Accreditive Leading Sizable & Cost-effective High-margin Positive M&A Yields Hospital, Fragmented R&D through End-to-end EBITDA & High-Value Community Global Market The Solutions Growing ARR Suite Of Agency & Achieving Innovations Generating Synergistic Mental Health Or